Chromocell Therapeutics (Chromocell Therapeutics) Other Current Liabilities : $0.49 Mil (As of Mar. 2024)

View and export this data going back to 2024. Start your Free Trial

What is Chromocell Therapeutics Other Current Liabilities?

Chromocell Therapeutics's other current liabilities for the quarter that ended in Mar. 2024 was $0.49 Mil.

Chromocell Therapeutics's quarterly other current liabilities increased from Sep. 2023 ($0.56 Mil) to Dec. 2023 ($0.65 Mil) but then declined from Dec. 2023 ($0.65 Mil) to Mar. 2024 ($0.49 Mil).

Chromocell Therapeutics's annual other current liabilities increased from Dec. 2021 ($0.00 Mil) to Dec. 2022 ($0.22 Mil) and increased from Dec. 2022 ($0.22 Mil) to Dec. 2023 ($0.65 Mil).

Chromocell Therapeutics Other Current Liabilities Historical Data

The historical data trend for Chromocell Therapeutics's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Chromocell Therapeutics Other Current Liabilities Chart

Chromocell Therapeutics Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Other Current Liabilities

Chromocell Therapeutics Quarterly Data
	Dec20	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Other Current Liabilities	Get a 7-Day Free Trial							-	-	-	-	-

Chromocell Therapeutics Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

Chromocell Therapeutics Other Current Liabilities Related Terms

Thank you for viewing the detailed overview of Chromocell Therapeutics's Other Current Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Chromocell Therapeutics (Chromocell Therapeutics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Chromocell Therapeutics Corp (AMEX:CHRO) » Definitions » Other Current Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

Chromocell Therapeutics Corp is a clinical-stage biotech company focused on developing and commercializing new therapeutics to alleviate pain. Its clinical focus is to selectively target the sodium ion-channel known as "NaV1.7", as well as other receptors in the NaV family. NaV1.7 has been genetically validated as a pain receptor in human physiology.